Exact Mass: 376.1535

Exact Mass Matches: 376.1535

Found 16 metabolites which its exact mass value is equals to given mass value 376.1535, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Entinostat

N-[[4-[(2-Aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester

C21H20N4O3 (376.1535)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

Picotamide

4-Methoxy-N1,N3-bis[(pyridin-3-yl)methyl]benzene-1,3-dicarboximidate

C21H20N4O3 (376.1535)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

(+)-Verrucine A

(+)-Verrucine A

C21H20N4O3 (376.1535)


   
   

Maybridge1_006713

Maybridge1_006713

C21H20N4O3 (376.1535)


   
   

Entinostat

Entinostat (MS-275)

C21H20N4O3 (376.1535)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

MS-275

N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid

C21H20N4O3 (376.1535)


   

[[5-[(Acetyloxy)methyl]-1-phenyl-1H-pyrazol-3-yl]methylene]phenylhydrazide acetic acid

[[5-[(Acetyloxy)methyl]-1-phenyl-1H-pyrazol-3-yl]methylene]phenylhydrazide acetic acid

C21H20N4O3 (376.1535)


   

4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)benzoic acid

4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)benzoic acid

C21H20N4O3 (376.1535)


   

Picotamide

Picotamide

C21H20N4O3 (376.1535)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

N2-(2,5-dimethoxyphenyl)-N4-(2-furanylmethyl)quinazoline-2,4-diamine

N2-(2,5-dimethoxyphenyl)-N4-(2-furanylmethyl)quinazoline-2,4-diamine

C21H20N4O3 (376.1535)


   

3-[(6s,9s)-8,11-dioxo-6-(phenylamino)-6h,7h,9h-pyrido[2,1-b]quinazolin-9-yl]propanimidic acid

3-[(6s,9s)-8,11-dioxo-6-(phenylamino)-6h,7h,9h-pyrido[2,1-b]quinazolin-9-yl]propanimidic acid

C21H20N4O3 (376.1535)


   

3-[(1s,4r)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

3-[(1s,4r)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

C21H20N4O3 (376.1535)


   

3-{1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}propanimidic acid

3-{1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}propanimidic acid

C21H20N4O3 (376.1535)


   

3-[(1s,4s)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

3-[(1s,4s)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

C21H20N4O3 (376.1535)